Status:
COMPLETED
Prevention for Mother-to-infant Transmission of HBV
Lead Sponsor:
Xi'an Jiaotong University
Conditions:
HBV
Eligibility:
FEMALE
Phase:
NA
Brief Summary
In this study, HBV-infected pregnant women were divided into two groups, those who received and those who did not receive hepatitis B immunoglobulin (HBIG) during pregnancy. In the mothers, the change...
Detailed Description
Twenty-eight HBsAg-positive pregnant women who underwent consultation were recruited from the First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China. Twelve of these women willing to r...
Eligibility Criteria
Inclusion
- HBsAg positive for more than 6 months, gestational age less than 20 weeks
Exclusion
- infection with toxoplasmosis, syphilis, parvovirus B19, rubella, cytomegalovirus, herpes, hepatitis C, HIV, or other viruses; obstetric diseases such as pregnancy-related hypertension, placental abruption, threatened miscarriage, and others.
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT02312531
Start Date
May 1 2012
End Date
August 1 2014
Last Update
December 9 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.